Zobrazeno 1 - 10
of 352
pro vyhledávání: '"Robertson Ah"'
Autor:
Mukherjee R; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. ratnadeep.mukherjee@fhi.no., Eggesbø LM; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Wolf AS; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Solum G; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Ravussin A; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Bhandari S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Robertson AH; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Trogstad L; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway., Kristoffersen AB; Division of Infection Control, Section for Modelling and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway., Nygaard UC; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Mjaaland S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2024 Nov 29; Vol. 9 (1), pp. 238. Date of Electronic Publication: 2024 Nov 29.
Autor:
Uthman OA; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Lyngse FP; Department of Economics & Center for Economic Behaviour and Inequality, University of Copenhagen, Copenhagen, Denmark., Anjorin S; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Hauer B; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Hakki S; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez DA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Ge Y; School of Health Professions, University of Southern Mississippi, Hattiesburg, Mississippi, United States of America., Jonnerby J; School of Public Health, Imperial College London, London, United Kingdom., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Lin G; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Lalvani A; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Loss J; Department of Epidemiology and Health Monitoring, Robert Koch-Institute, Berlin, Germany., Madon KJ; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez L; Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America., Næss LM; School of Public Health, Imperial College London, London, United Kingdom., Page KR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Prieto D; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Robertson AH; School of Public Health, Imperial College London, London, United Kingdom., Shen Y; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, United States of America., Wurm J; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Buchholz U; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Publikováno v:
PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0306740. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).
Autor:
Tunheim G; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway. gro.tunheim@fhi.no., Fossum E; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Robertson AH; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Rø GØI; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Chopra A; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway., Vaage JT; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway., Vikse EL; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Kran AB; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Magnus P; Center for Fertility and Health, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Trogstad L; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Mjaaland S; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Hungnes O; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2024 Aug 20; Vol. 24 (1), pp. 841. Date of Electronic Publication: 2024 Aug 20.
Autor:
Blix K; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Laake I; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Juvet L; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway., Robertson AH; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Caspersen IH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Mjaaland S; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Skodvin SN; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Feiring B; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Trogstad L; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Science advances [Sci Adv] 2023 Sep 22; Vol. 9 (38), pp. eadg1391. Date of Electronic Publication: 2023 Sep 22.
Autor:
Trogstad L; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Laake I; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: ida.laake@fhi.no., Robertson AH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Mjaaland S; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Caspersen IH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Juvet LK; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Blix K; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Feiring B; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Vaccine [Vaccine] 2023 Aug 14; Vol. 41 (36), pp. 5271-5282. Date of Electronic Publication: 2023 Jul 03.
Autor:
Jordan K; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Murchu EO; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Comber L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Teljeur C; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Harrington P; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Carnahan A; Public Health Agency of Sweden, Solna, Sweden.; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden., Pérez-Martín JJ; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Murcia, Spain., Robertson AH; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Jonge J; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Krause T; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; School of Health Sciences, Faculty of Nursing, Pediatric Research Laboratory, National and Kapodistrian University of Athens, Athens, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Ryan M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity. Health Sciences, Dublin, Ireland.
Publikováno v:
Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2332. Date of Electronic Publication: 2022 Feb 08.
Autor:
Ravussin A; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Robertson AH; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: anna.hayman.robertson@fhi.no., Wolf AS; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Blix K; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Solum G; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Feiring B; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway., Strand BH; Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell Malignancies, University of Oslo, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Trogstad L; Division of Infection Control, Section for Vaccine Epidemiology and Population Studies, Norwegian Institute of Public Health, Oslo, Norway., Mjaaland S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
The lancet. Healthy longevity [Lancet Healthy Longev] 2023 May; Vol. 4 (5), pp. e188-e199.
Autor:
O Murchu E; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Comber L; Health Information and Quality Authority (HIQA), Dublin, Ireland., Jordan K; Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Information and Quality Authority (HIQA), Dublin, Ireland., Ryan M; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity Health Sciences, Trinity College Dublin, Dublin, Ireland., Teljeur C; Health Information and Quality Authority (HIQA), Dublin, Ireland., Carnahan A; Public Health Agency of Sweden, Solna, Sweden., Pérez JJ; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Region of Murcia, Spain., Robertson AH; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, Stockholm, Sweden., Jonge J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Krause T; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; Pediatric Research Laboratory, School of Health Sciences, Faculty of Nursing, National Kapodistrian University of Athens, Athens, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Harrington P; Health Information and Quality Authority (HIQA), Dublin, Ireland.
Publikováno v:
Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2331. Date of Electronic Publication: 2022 Feb 02.
Autor:
Comber L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O Murchu E; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Jordan K; Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Information and Quality Authority (HIQA), Dublin, Ireland., Teljeur C; Health Information and Quality Authority (HIQA), Dublin, Ireland., Ryan M; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Health Sciences, Dublin, Ireland., Carnahan A; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Public Health Agency of Sweden, Solna, Sweden., Pérez Martín JJ; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Region of Murcia, Spain., Robertson AH; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., de Jonge J; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; National Institute for Public Health and the Environment, Center for Infectious Disease Control, Bilthoven, The Netherlands., Krause T; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Pediatric Research Laboratory, School of Health Sciences, Faculty of Nursing, National & Kapodistrian University of Athens, Goudi, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) Collaboration on Newer and Enhanced Inactivated Seasonal Influenza Vaccines, Solna, Sweden.; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Harrington P; Health Information and Quality Authority (HIQA), Dublin, Ireland.
Publikováno v:
Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2330. Date of Electronic Publication: 2022 Feb 04.
Autor:
O Murchu E; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Comber L; Health Information and Quality Authority (HIQA), Dublin, Ireland., Jordan K; Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Information and Quality Authority (HIQA), Dublin, Ireland., Ryan M; Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Health Sciences, Dublin, Ireland., Teljeur C; Health Information and Quality Authority (HIQA), Dublin, Ireland., Carnahan A; Public Health Agency of Sweden, Solna, Sweden., Pérez JJ; General Directorate of Public Health and Addictions, IMIB-Arrixaca. Murcia University, Region of Murcia, Spain., Robertson AH; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, Solna, Sweden., Jonge J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Krause T; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, Solna, Sweden., Nohynek H; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; Pediatric Research Laboratory, School of Health Sciences, Faculty of Nursing National and Kapodistrian University of Athens, Athens, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, Solna, Sweden., Soler-Soneira M; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Harrington P; Health Information and Quality Authority (HIQA), Dublin, Ireland.
Publikováno v:
Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2329. Date of Electronic Publication: 2022 Feb 10.